当前位置: 首页 > 期刊 > 《湖南中医药大学学报》 > 2022年第1期
编号:441868
活血化瘀法和补益法协同在肿瘤化疗后骨髓抑制中的运用
http://www.100md.com 2022年2月19日 湖南中医药大学学报 2022年第1期
     谭彩 王理槐 冯君 王伟松 刘建和

    〔摘要〕 骨髓抑制是恶性肿瘤化疗后的常见不良反应。化疗药物入血,損伤血络,致血脉空虚、气血瘀滞,加上化疗后元气虚衰,无力推动血液运行,致使血停而为瘀,影响新血生成,“瘀血不去,新血不生”。因此,临证中在补益正气的前提下,同时因人制宜、辨证活血化瘀,使益气与行血并行,可祛瘀生新、推陈出新,促进骨髓造血,从而可有效改善骨髓抑制。

    〔关键词〕 肿瘤;化疗;骨髓抑制;活血化瘀;补益;祛瘀生新

    〔中图分类号〕R259 ? ? ? 〔文献标志码〕A ? ? ? ?〔文章编号〕doi:10.3969/j.issn.1674-070X.2022.01.016

    〔Abstract〕 Myelosuppression is a common adverse reaction after chemotherapy for malignant tumors. Chemotherapy drugs enter the blood, injure the blood collateralization, cause empty blood vessels and stagnation of Qi and blood stasis. In addition, after chemotherapy, Yuan Qi deficiency and failure, unable to promote the movement of blood, resulting in blood stagnation and blood stasis, affecting the generation of new blood, "blood stasis is not removed, new blood is not born". Therefore, on the premise of replenishing vital Qi, we should according to individual conditions, syndrome differentiation for promoting blood circulation and removing blood stasis, so that Qi and blood circulation are in parallel. By removing blood stasis and generating new, pushing through the old and bringing forth the new to promote bone marrow hematopoiesis and effectively improve bone marrow suppression. ......

您现在查看是摘要页,全文长 14533 字符